Pernix Therapeutics Inc. Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Pernix Therapeutics (PTX) Posts Q1 Loss of 62c/Share
May 1, 2015 6:52 AM EDTPernix Therapeutics (NASDAQ: PTX) reported Q1 EPS of ($0.62), which may not compare with the analyst estimate of ($0.02). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $34.55 million.
On a non-GAAP basis, 1Q 2015 adjusted net loss was $4.0 million versus... More
